 | Avenue Therapeutics, Inc. | |||
| NCM : ATXI || Location: United States | ||||
$0.130.0 (0.0%) |
1.61 M | 0.11 - 0.14 | ||
| Last Updated:America/New_York | Volume | Day range |
Short Interest
| Short Date | Short Interest |
|---|---|
| March 28, 2024 | 0.283 M |
| March 15, 2024 | 0.313 M |
| Feb. 29, 2024 | 0.163 M |
| Feb. 15, 2024 | 0.338 M |
| Jan. 31, 2024 | 0.677 M |
EPS Surprise
| Period | Estimate | Actual | Surprise |
|---|---|---|---|
| 12/31/2023 | -0.10 | 0.06 | 158.82% |
| 09/30/2023 | -0.27 | 0.06 | 122.62% |
| 06/30/2023 | -0.30 | -0.52 | -75.79% |
| 03/31/2023 | -0.13 | -1.35 | -918.10% |
| 12/31/2022 | -0.15 | 0.26 | 269.93% |
ATXI Basic Data
| Sector | Healthcare | Industry | Biotechnology |
| Shares Outstanding | 44.261M | Shares Float | 39.439M |
| Short Float | 0.283M | Market Cap | 5.75M |
| Institution ownership | 2.80% | Insider ownership | 10.879% |
| Earnings Date | 05/13/2024 AMC | Cash Per Share | ? |
| Trailing EPS | -0.98 | Forward EPS | -0.37 |